Vitamin deficiency risk rises when both agents are used together
Then, in February 2025, FDA removed semaglutide from its shortage list, giving some pharmacies, called 503A pharmacies, until April 22, 2025, to stop dispensing exact copies of semaglutide, and others, so-called 503B pharmacies, until May 22, 2025
Factors like your medical history, potential side effects, insurance coverage, and how your body responds to treatment all play a role
The key is the trend over months, not weeks
The overall pattern is consistent: most gastrointestinal side effects peak during dose escalation, diminish within weeks, and become minimal at stable maintenance doses